More Considerations for Risk Stratification of Fetal Atrioventricular Block Beyond Anti‐Ro Titer: comment on the article by Buyon et al
- 1 February 2024
- journal article
- letter
- Published by Wiley in Arthritis & Rheumatology
- Vol. 76 (6) , 985-986
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti‐SSA/Ro PregnanciesArthritis & Rheumatology, 2023
- Maternal Anti‐Ro Antibody Titers Obtained With Commercially Available Immunoassays Are Strongly Associated With Immune‐Mediated Fetal Heart DiseaseArthritis & Rheumatology, 2023
- Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysisPediatric Rheumatology, 2023
- Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive MothersJACC, 2020
- EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapiesAnnals of the Rheumatic Diseases, 2020